Financial analyst by day and a seasoned investor by passion, I've been involved in the world of investing for over 10 years and honed my skills in analyzing lucrative opportunities within the market.I specialize in uncovering strategies to utilize various investment vehicles - seeking out high quality dividend stocks, and other assets that offer potential for long term-growth that pack a serious punch for bill-paying potential. I use myself as an example that with a solid base of classic dividend growth sto ...

Brian Gilmartin, is a portfolio manager at Trinity Asset Management, a firm he founded in May, 1995, catering to individual investors and institutions that werent getting the attention and service deserved, from larger firms. Brian started in the business as a fixed-income / credit analyst, with a Chicago broker-dealer, and then worked at Stein Roe & Farnham in Chicago, from 1992 - 1995, before striking out on his own and managing equity and balanced accounts for clients. Brian has a BSBA (Finance) from Xav ...

The "Dogs of the Dow" strategy involves investing each year in the 10 highest-yielding stocks from the 30 constituents of the Dow Jones Industrial Average. Pfizer Inc. (NYSE: PFE ) was one of these and droppedAdvanced education in economics, business management and engineering. Professional experience with product management and development in high tech industry, including advisory with multiple fintech startups. Have been investing in growth companies since 1998. Recent interest of investment also includes ...

I analyze oil and gas companies like Comstock Resources and related companies in my service, Oil & Gas Value Research, where I look for undervalued names in the oil and gas space. I break down everything you need to know about these companies -- the balance sheet, competitive position and development prospects. This article is an example of what I do. But for Oil & Gas Value Research members, they get it first, and they get analysis on some companies that is not published on the free site. Interested? Sign ...

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in MRT over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.This piece reflects my honest market outl ...

Company Performance - Grab Holdings Limited (NASDAQ: GRAB) experienced a significant decline of 86% from the end of 2021 to mid-2022, dropping to $2 26 and struggling to rise above $4 for approximately two and a half years [1] - The company has recently begun to reverse this negative trend [1] Analyst Background - Yavuz Akbay is a quantitative analyst with over 5 years of experience in interpreting complex financial data, developing mathematical models, and forecasting [1] - Yavuz utilizes machine learning algorithms to enhance financial analysis and provide accurate recommendations [1] - Yavuz holds a Bachelor of Business Administration and is currently pursuing a Master's in Economics [1]

A financial researcher and avid investor with a keen eye for innovation and disruption, as well as growth buy-outs and value stocks. Keeping an eye on the pace of high tech and early growth companies, I write about current events and the biggest news surrounding the industry, and strive to provide readers with ample research and investment opportunities.Analyst’s Disclosure: I/we have a beneficial long position in the shares of DX either through stock ownership, options, or other derivatives. I wrote this a ...

I'm surprised I am doing another article on AVITA Medical (NASDAQ: RCEL ) so soon after my previous one, which came out on January 2nd . Unfortunately, my article was very poorly timed given the recent sales update, whichAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (oth ...

Acquisition and Market Impact - Constellation Energy announced a $26.6 billion deal to acquire rival Calpine, expanding its footprint in Texas, California, and the Northeast [2] - The transaction includes stock, cash, and the assumption of approximately $12.7 billion of Calpine's net debt [2] - Constellation Energy shares surged more than 25% on Friday following the acquisition announcement [2][10] Stock Performance and Demand Drivers - Constellation Energy shares have more than doubled in the last year and are up 36% year-to-date (YTD) as of Friday's close [3] - The company's stock performance is boosted by increasing power demand to meet AI computing resources [3] - Constellation Energy plans to restart the Three Mile Island Unit 1 nuclear plant in Pennsylvania to provide electricity for Microsoft's data centers [3] Technical Analysis and Price Targets - Constellation Energy shares broke out from a falling wedge pattern earlier this month and reached a new all-time high (ATH) on Friday [5][10] - The breakout occurred on the third-highest trading volume day since the company went public in early 2022, indicating strong buying conviction [5] - The relative strength index (RSI) confirms bullish momentum but also indicates overbought conditions, suggesting potential short-term profit-taking [6] - Bars pattern analysis forecasts an upside price target of around $350, approximately 15% above Friday's closing price [7][10] Key Support Levels - Investors should monitor the $280 level as a key support area during retracements [9][10] - A failure to defend the $280 level could lead to a pullback to around $236, where multiple support levels converge, including the 50-day moving average and the falling wedge pattern's upper trendline [11]

Analyst’s Disclosure: I/we have a beneficial long position in the shares of LNC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give financial advice ...